Can I Take Vitamin D with Oral Micronized Progesterone?

The Short Answer: Vitamin D and Prometrium Are Safe Together

No interaction database, including Natural Medicines Comprehensive Database and the FDA drug interaction data, lists a contraindication or dose-limiting interaction between oral micronized progesterone and vitamin D. The two compounds travel different absorption routes, are metabolized by different enzyme families, and act on completely separate receptor systems. Taking both is not only safe but often clinically appropriate, because vitamin D insufficiency is common in women who are candidates for hormone replacement therapy.

A 2011 National Health and Nutrition Examination Survey (NHANES) analysis found that approximately 41.6% of U.S. Adults had serum 25-hydroxyvitamin D levels below 20 ng/mL, which meets the threshold for deficiency. [1] Women in perimenopause and menopause, the population most likely to be prescribed Prometrium, were among the higher-risk groups.

How Oral Micronized Progesterone Is Absorbed and Metabolized

The CYP450 Pathway for Prometrium

Oral micronized progesterone is absorbed in the small intestine with the help of dietary fat, which is why the FDA-approved labeling recommends taking Prometrium with food or at bedtime after a snack. After absorption, progesterone undergoes extensive first-pass hepatic metabolism. The primary enzymes involved are CYP3A4 and CYP2C19, producing active metabolites including allopregnanolone and 20-alpha-dihydroprogesterone. [2]

Why This Matters for Interactions

A drug-supplement interaction becomes clinically meaningful when one compound inhibits or induces the enzymes that process the other, or when they compete for the same transporter proteins. Vitamin D does not inhibit or induce CYP3A4 or CYP2C19 at any physiologically achievable serum concentration. Conversely, progesterone does not affect the enzymes responsible for converting vitamin D to its active form (25-hydroxylation in the liver via CYP2R1, and 1-alpha-hydroxylation in the kidney via CYP27B1). [3]

The two pathways are, for practical purposes, orthogonal.

How Vitamin D Is Absorbed and Activated

Absorption Mechanics

Vitamin D3 (cholecalciferol) from supplements is absorbed in the jejunum and ileum alongside dietary fats, packaged into chylomicrons, and transported via the lymphatic system to the liver. [4] Vitamin D2 (ergocalciferol) follows a similar route but has a shorter half-life in serum. Both forms are subsequently hydroxylated in the liver to 25-hydroxyvitamin D (calcidiol), the storage and testing form.

The final activation step occurs in the kidney, where 25-OH-D is converted to 1,25-dihydroxyvitamin D (calcitriol), the hormonally active metabolite that regulates calcium absorption and bone mineralization.

Receptor Targets

Calcitriol binds the vitamin D receptor (VDR), a nuclear receptor that controls gene expression in intestinal epithelial cells, osteoblasts, immune cells, and parathyroid glands. Progesterone binds the progesterone receptor (PR), a separate nuclear receptor that is structurally related but functionally distinct. Neither ligand has meaningful affinity for the other's receptor at physiological concentrations. [5]

Why Vitamin D Levels Matter Specifically for Women on HRT

Bone Density and the Estrogen-Vitamin D Link

One of the primary reasons women take HRT, including the endometrial-protective progestogen component (Prometrium), is to preserve bone mineral density during the estrogen-depleted years after menopause. Estrogen upregulates intestinal calcium absorption partly by increasing renal CYP27B1 activity, which raises calcitriol production. [6] When estrogen falls, this mechanism weakens, and adequate vitamin D intake becomes even more important to maintain calcium homeostasis.

The Women's Health Initiative (WHI) calcium and vitamin D trial (N=36,282) found that women assigned to calcium 1,000 mg plus vitamin D3 400 IU daily had modestly higher hip bone mineral density at 9 years compared with placebo, though the dose used was now considered subtherapeutic by current guidelines. [7] The Endocrine Society's 2011 clinical practice guideline recommends 1,500 to 2,000 IU/day of vitamin D for adults who need to raise serum levels, explicitly noting that 400 IU is insufficient for most people. [8]

Parathyroid Hormone and Bone Resorption

When serum 25-OH-D falls below 20 ng/mL, the parathyroid glands compensate by secreting more PTH. Elevated PTH increases osteoclast activity, accelerating bone resorption. This secondary hyperparathyroidism can partially offset the bone-protective effect of HRT. Correcting vitamin D deficiency before or during HRT initiation removes that competing signal.

A 2013 meta-analysis in the Journal of Clinical Endocrinology and Metabolism (17 RCTs, N=2,016) found that vitamin D supplementation reduced PTH concentrations by a mean of 7.0 pg/mL (95% CI 3.5 to 10.5), with greater reductions in participants who started with lower baseline 25-OH-D levels. [9]

Pharmacodynamic Considerations: Does Progesterone Affect Vitamin D Status?

Progesterone and the Vitamin D Receptor

There is emerging evidence from cell and animal studies that sex steroids, including progesterone, can modulate VDR gene expression in certain tissues such as the uterus and placenta. [10] However, this crosstalk has not been shown in human RCTs to produce measurable changes in serum 25-OH-D concentrations or to alter the clinical response to vitamin D supplementation.

Clinically, women starting Prometrium do not need to adjust their vitamin D dose solely because of progesterone exposure.

Progesterone's Mild Mineralocorticoid Antagonism

Oral micronized progesterone has mild anti-mineralocorticoid activity, which can cause a slight natriuretic and diuretic effect at higher doses. This does not affect calcium, phosphate, or vitamin D metabolism in any clinically documented way. Synthetic progestins such as medroxyprogesterone acetate (MPA), by contrast, have different receptor profiles and should not be conflated with micronized progesterone when reviewing interaction data.

The HealthRX Three-Step Pre-HRT Micronutrient Check

Before starting Prometrium or any HRT regimen, the HealthRX clinical team recommends:

1. Baseline 25-OH-D level. Target 40 to 60 ng/mL. Below 30 ng/mL meets the Endocrine Society's insufficiency threshold and warrants supplementation.
2. Calcium intake audit. Dietary calcium should reach 1,000 to 1,200 mg/day from food first; supplements fill the gap.
3. Renal function screen. Impaired kidney function reduces CYP27B1 activity and may require activated vitamin D (calcitriol) rather than standard cholecalciferol.

This three-step pre-HRT check is not currently codified in any single national guideline but reflects the composite of recommendations from the Endocrine Society [8], the North American Menopause Society (NAMS) [11], and the National Osteoporosis Foundation.

Dosing: What Amounts of Vitamin D Are Appropriate?

Standard Supplementation Ranges

The Endocrine Society's 2011 practice guideline, authored by Michael Holick and colleagues, states: "For adults 19 to 50 years of age, we recommend at least 600 IU of vitamin D daily to maximize bone health and muscle function. To raise the blood level of 25-OH-D consistently above 30 ng/mL may require at least 1,500 to 2,000 IU of vitamin D daily." [8]

For women in menopause, 1,000 to 2,000 IU of vitamin D3 daily is the range most commonly recommended by NAMS and the National Osteoporosis Foundation. Doses above 4,000 IU/day require physician oversight and periodic serum monitoring to avoid hypercalcemia.

Toxicity Threshold

Vitamin D toxicity (hypervitaminosis D) is rare at doses below 10,000 IU/day in adults with normal kidney and parathyroid function. The Institute of Medicine sets the tolerable upper intake level at 4,000 IU/day as a conservative threshold. [12] Serum 25-OH-D above 150 ng/mL is associated with hypercalcemia and requires prompt dose reduction.

Women with sarcoidosis, Williams syndrome, or primary hyperparathyroidism are at higher risk of hypercalcemia with even modest vitamin D supplementation and must be monitored more closely. These conditions are not contraindications to Prometrium, but they change the vitamin D equation substantially.

Timing Relative to Prometrium

No timing separation is required. Both Prometrium and vitamin D supplements are absorbed more completely with food or dietary fat. [2][4] Taking both at the same meal is convenient and does not reduce the bioavailability of either compound.

Many clinicians recommend taking Prometrium at bedtime because allopregnanolone, its neurosteroid metabolite, has a sedating effect. Vitamin D can be taken at the same bedtime dose or with any fat-containing meal during the day. Either approach is acceptable.

Monitoring Parameters When Taking Both

Initial Lab Work

Before starting or adjusting either therapy, the following baseline labs provide the most useful clinical picture:

• Serum 25-OH-D (target: 40 to 60 ng/mL for bone health in menopause)
• Serum calcium and albumin (to calculate corrected calcium)
• PTH if calcium is borderline or vitamin D is severely deficient
• Basic metabolic panel, especially if renal disease is suspected

Follow-Up Schedule

Recheck 25-OH-D at 3 months after starting or changing vitamin D supplementation. Once the target serum level is confirmed, annual monitoring is adequate in stable patients. No additional progesterone-specific lab monitoring is required because of vitamin D co-administration.

The FDA-approved prescribing information for Prometrium does not list any laboratory monitoring requirements that change based on concurrent vitamin D use. [2]

Special Populations

Women with Osteopenia or Osteoporosis

This group has the most to gain from optimizing vitamin D while on HRT. The combination of estrogen (endometrial protection provided by Prometrium) and adequate vitamin D and calcium is considered standard of care for preventing further bone loss. NAMS states: "Hormone therapy remains the most effective treatment for menopause-related bone loss and is appropriate for recently menopausal women." [11] Vitamin D optimization amplifies this effect by ensuring calcium absorption is not rate-limited.

Pregnant Women

Prometrium is used in early pregnancy to support the luteal phase in assisted reproductive technology (ART) cycles. Vitamin D is safe in pregnancy. The American College of Obstetricians and Gynecologists (ACOG) recommends that pregnant women take at least 600 IU of vitamin D daily and notes that 1,000 to 2,000 IU is safe. [13] The interaction profile does not change in pregnancy.

Women with PCOS

Polycystic ovary syndrome is associated with both low vitamin D levels and progesterone deficiency (due to anovulation). A 2019 meta-analysis in Reproductive BioMedicine Online (10 RCTs, N=601) found that vitamin D supplementation in women with PCOS significantly improved menstrual regularity and reduced fasting insulin, with a weighted mean difference of -2.35 mIU/mL (P<0.01). [14] Women with PCOS receiving progesterone for cycle regulation may see compounded metabolic benefit from correcting vitamin D deficiency.

What the Interaction Databases Actually Say

Natural Medicines Comprehensive Database, the peer-reviewed supplement interaction resource used by most pharmacists and physicians, classifies the vitamin D and progesterone interaction as "no known interaction." The Drugs.com interaction checker returns the same result for cholecalciferol and progesterone. The absence of a listed interaction reflects the genuine absence of mechanistic or clinical evidence of harm, not a gap in the database.

By comparison, actual clinically significant interactions with Prometrium include CYP3A4 inducers such as rifampicin (which can reduce progesterone plasma levels by 50 to 70%) and CYP3A4 inhibitors such as ketoconazole (which may increase progesterone exposure). [2] Vitamin D is categorized in neither group.

Practical Guidance: How to Take Both Safely

Step-by-Step Protocol

1. Get a serum 25-OH-D level before starting supplementation.
2. Choose vitamin D3 (cholecalciferol) over D2 (ergocalciferol); D3 raises serum levels more efficiently and has a longer half-life. [15]
3. Take 1,000 to 2,000 IU of vitamin D3 daily with a fat-containing meal. Evening dosing alongside Prometrium is fine.
4. Recheck 25-OH-D at 3 months. Adjust dose to reach 40 to 60 ng/mL.
5. If 25-OH-D remains below 30 ng/mL at 3 months on 2,000 IU/day, discuss a short-term loading protocol (e.g., 50,000 IU vitamin D2 or D3 weekly for 8 weeks) with your prescribing clinician. [8]
6. Once stable, annual monitoring suffices.

Red Flags to Report to Your Clinician

Contact your provider if you experience nausea, excessive thirst, frequent urination, or muscle weakness while on high-dose vitamin D. These symptoms may indicate hypercalcemia, which requires a serum calcium check, not a change to your progesterone.